Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Nanexa AB | 206,000 | net | 03 Nov 2023 | tx 2+206,000 |
| Chordate Medical Holding AB (publ) | 32,000 | net | 14 Mar 2025 | tx 3+32,000 |
| Asarina Pharma AB | 19,005 | net | 21 Feb 2020 | tx 3+19,005 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 14 Mar 2025 | PURCHASE | Chordate Medical Holding AB (publ) | 3,500 | 8.00 SEK | |
| 14 Mar 2025 | PURCHASE | Chordate Medical Holding AB (publ) | 3,500 | 4.00 SEK | |
| 28 Feb 2025 | PURCHASE | Chordate Medical Holding AB (publ) | 25,000 | 12.00 SEK | first after silence |
| 03 Nov 2023 | PURCHASE | Nanexa AB | 100,000 | 1.00 SEK | first after silence |
| 10 Jun 2020 | PURCHASE | Nanexa AB | 106,000 | 1.15 SEK | deriv |
| 21 Feb 2020 | PURCHASE | Asarina Pharma AB | 2,005 | 35.00 SEK | |
| 24 Sept 2019 | PURCHASE | Asarina Pharma AB | 2,000 | 25.50 SEK | first after silence |
| 18 Sept 2018 | PURCHASE | Asarina Pharma AB | 15,000 | 21.00 SEK |
3 purchases reported after at least 12 months of silence — most recent on 28 Feb 2025.